Reuters logo
3 years ago
BRIEF-Biofrontera AG says pre-NDA meeting scheduled with FDA for approval of Ameluz and BF-RhodoLED
August 21, 2014 / 12:35 PM / 3 years ago

BRIEF-Biofrontera AG says pre-NDA meeting scheduled with FDA for approval of Ameluz and BF-RhodoLED

Aug 21 (Reuters) - Biofrontera AG : * Says pre-NDA meeting scheduled with FDA for the approval of Ameluz and BF-RhodoLED * Says has scheduled the pre-NDA (new drug application) meeting for 8 October

2014 * Source text for Eikon * Further company coverage

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below